This study demonstrates that the hydrodynamic injection of CTRP1 improves glucose homeostasis and prevents HFD-induced obesity, adipose hypertrophy, and fatty liver due to upregulated energy expenditure, thermogenesis, lipolysis, and reduced inflammation and food intake. The gene discussed is C1QTNF1; the disease is obesity due to melanocortin 4 receptor deficiency.